Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Study Designs in Epidemiology01:20

Study Designs in Epidemiology

1.6K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

383
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

419
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
419
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

600
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
600

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss function influence on hyperparameter optimization for observational healthcare prediction models.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Addressing Small Data Challenges in Biopharmaceutical Development and Manufacturing: A Mini Review of Multi-Fidelity Techniques.

Biotechnology and bioengineering·2026
Same author

Mind the Gap: Human and AI Uncertainties in Cardiac MRI Segmentation.

Cardiovascular engineering and technology·2026
Same author

Oscillatory Correlates of Habituation: EEG Evidence of Sustained Frontal Theta Activity to Food Cues.

Sensors (Basel, Switzerland)·2026
Same author

The use of fully immersive virtual reality for screening neurodegenerative diseases: A systematic review of behavioral and diagnostic outcomes.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Retraction notice to "Novel dynamic fuzzy decision-making framework for COVID-19 vaccine dose recipients" [J. Adv. Res. 37 (2022) 147-168].

Journal of advanced research·2025

Related Experiment Video

Updated: May 2, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

928

Signalling paediatric side effects using an ensemble of simple study designs.

Jenna M Reps1, Jonathan M Garibaldi, Uwe Aickelin

  • 1IMA, The University of Nottingham, Nottingham, NG8 1BB, UK, psxjr1@nottingham.ac.uk.

Drug Safety
|February 20, 2014
PubMed
Summary

This study developed a supervised framework to detect adverse drug reactions in children, outperforming individual methods. The approach effectively signals potential side effects using historical data, improving pediatric medication safety.

More Related Videos

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

840
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

10.8K

Related Experiment Videos

Last Updated: May 2, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

928
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

840
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

10.8K

Area of Science:

  • Pharmacovigilance
  • Pediatric Drug Safety
  • Computational Epidemiology

Background:

  • Children often receive medications off-label due to limited safety and efficacy data.
  • Ethical restrictions in clinical trials prevent comprehensive pediatric drug testing.
  • Existing pharmacovigilance methods are largely unsupervised.

Purpose of the Study:

  • To evaluate an ensemble of simple study designs for detecting acute side effects in children.
  • To introduce a supervised framework for pediatric pharmacovigilance.
  • To utilize historical longitudinal data for improved drug safety signaling.

Main Methods:

  • Calculating multiple measures of association for drug-event pairs.
  • Employing a supervised classifier trained on known adverse drug reactions (ADRs).
  • Using these measures as features to predict the likelihood of an ADR.

Main Results:

  • The novel ensemble framework achieved a false positive rate of 0.149.
  • Sensitivity was 0.547 and specificity was 0.851 on a reference dataset.
  • The ensemble approach consistently outperformed individual study designs.

Conclusions:

  • A causal mechanism-based framework can effectively signal adverse drug reactions.
  • This supervised approach enhances the detection of drug-induced side effects in pediatric populations.
  • The findings support improved safety monitoring for pediatric medications.